Searched for
COVAXIN CLINICAL TRIALS
Covaxin's clinical trials can resume in US as FDA lifts holdThe FDA's earlier decision, in April, to put on hold the trials was based on the US firm's decision to voluntarily implement a temporary pa...- Bharat Biotech's Covaxin gets nod for human trials in the US"We are pleased to be able to move our clinical program for Covaxin forward, which we hope will bring us closer to offering an alternative ...
- Bharat Biotech claims 77.8% efficacy of Covaxin in phase-3 trialsAnnouncing the much awaited safety and efficacy data from phase-3 clinical trials of Covaxin, the IMCR director Prof Balram Bhargava said C...
- Bharat Biotech shares elaborate data of all research studies of CovaxinCovaxin, a whole-virion inactivated coronavirus vaccine, is the first and only product to have published any data from human clinical trial...
- Covaxin trials begin for children at AIIMS PatnaEarlier in the week, NITI Aayog's Member Health, Dr V.K. Paul said: "Covaxin has been approved by the Drugs Controller General of India (DC...
- Paediatric trials of Covaxin may begin in June: Bharat Biotech officialThe efficacy of the jab can be improved upto 100 per cent protection by the COVID-19 appropriate behaviour and following other safety proto...
- Bharat Biotech's Covaxin recommended by expert panel for phase 2/3 trials on 2-18 year-oldsThe Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organization deliberated upon Hyderabad-based Bharat Biotech...
- Covaxin shows 100% efficacy against severe Covid-19, works well on variants“The tireless efforts of our scientists at ICMR and BBIL have resulted in a truly effective international vaccine of the highest standards ...
- Chhattisgarh, Punjab, Kerala shed Covaxin hesitancyCongress-ruled Chhattisgarh would deploy the vaccine in government medical colleges and government hospitals from Monday.
- DGCI's Subject Expert Committee recommends waiving off 'clinical trial mode' from CovaxinAfter more than two hours of deliberation on Wednesday, the SEC in its recommendation to the drug regulator asked for the removal of clinic...
- Bharat Bio seeks review of clinical trial mode for Covaxin VaccineThe drug regulator’s subject expert committee (SEC) will meet on Thursday to consider the vaccine maker’s request and review the data. “The...
- Bharat Biotech approaches DCGI, seeks Covaxin's removal from 'clinical trial mode'The vaccine was granted approval “for restricted use in emergency situation in public interest as an abundant precaution, in clinical trial...
- 13,000 volunteers administered 2nd dose of Covaxin in phase-3 trials: Bharat BiotechCovaxin is India's totally indigenous COVID-19 vaccine developed in collaboration with the Indian Council of Medical Research and National ...
- Bharat Biotech warns that Covaxin should not be used in case of allergies, fever and poor immunityBharat Biotech, makers of India's first indigenous vaccine for Covid-19, has advised people not to take 'Covaxin' if they have allergies, f...
- Bharat Biotech to pay compensation if Covaxin causes side effects"The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vacci...
- Healthcare NGO raises concerns over CovaxinA day before India begins the world’s largest Covid-19 vaccination drive, a group of healthcare-focused NGOs has sought clarifications from...
- Stop Bharat Biotech's coronavirus vaccine trial in Bhopal, plead NGOs working for gas victimsIn the letters addressed to the PM and Union Health Minister Harsh Vardhan, these NGOs have also sought punishment for the "responsible par...
- Bharat Biotech recruits 23,000 volunteers for Phase III trials of its coronavirus vaccineThe Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers and it is the countrys first an...
- After Haryana's Anil Vij tests positive, Bharat Biotech says COVAXIN efficacious, safe"COVAXIN clinical trials are based on a two-dose schedule, given 28 days apart. The vaccine efficacy will be determined 14 days after the s...
- Bharat Biotech starts human trial of its anti-COVID vaccine at PGI Rohtak: Minister Vij“Human trial with Corona vaccine (COVAXIN) of Bharat Biotech started at PGI Rohtak today,” Vij, who is also the Home and Science & Technolo...
Load More
